PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025
PAVmed (Nasdaq: PAVM, PAVMZ), a diversified commercial-stage medical technology company, has announced a business update conference call and webcast scheduled for May 15, 2025, at 8:30 AM ET. During the call, Chairman and CEO Lishan Aklog, M.D., will provide a business update and overview of operations and growth strategy, while President and CFO Dennis McGrath will discuss Q1 2025 financial results.
The webcast will be accessible through PAVmed's investor relations website. U.S. callers can dial 1-800-836-8184, and international callers can dial 1-646-357-8785 to join the "PAVmed Business Update" call. A 30-day replay will be available on the company's website following the conference.
PAVmed (Nasdaq: PAVM, PAVMZ), un'azienda diversificata nel settore delle tecnologie mediche a livello commerciale, ha annunciato una conferenza telefonica e webcast per l'aggiornamento aziendale, programmata per il 15 maggio 2025 alle 8:30 AM ET. Durante la chiamata, il Presidente e CEO Lishan Aklog, M.D., fornirà un aggiornamento sull'andamento aziendale e una panoramica delle operazioni e della strategia di crescita, mentre il Presidente e CFO Dennis McGrath illustrerà i risultati finanziari del primo trimestre 2025.
Il webcast sarà accessibile tramite il sito web delle relazioni con gli investitori di PAVmed. Gli ascoltatori negli Stati Uniti possono chiamare il numero 1-800-836-8184, mentre quelli internazionali possono utilizzare il numero 1-646-357-8785 per partecipare alla chiamata "Aggiornamento Aziendale PAVmed". Una replica della chiamata sarà disponibile per 30 giorni sul sito web dell'azienda dopo la conferenza.
PAVmed (Nasdaq: PAVM, PAVMZ), una empresa diversificada de tecnología médica en etapa comercial, ha anunciado una llamada y webcast para una actualización empresarial programada para el 15 de mayo de 2025 a las 8:30 AM ET. Durante la llamada, el presidente y CEO Lishan Aklog, M.D., ofrecerá una actualización del negocio y una visión general de las operaciones y la estrategia de crecimiento, mientras que el presidente y CFO Dennis McGrath presentará los resultados financieros del primer trimestre de 2025.
El webcast estará disponible a través del sitio web de relaciones con inversores de PAVmed. Los llamantes en EE. UU. pueden marcar 1-800-836-8184, y los internacionales pueden llamar al 1-646-357-8785 para unirse a la llamada "Actualización Empresarial de PAVmed". Una repetición estará disponible durante 30 días en el sitio web de la compañía después de la conferencia.
PAVmed (나스닥: PAVM, PAVMZ)는 다양한 상업 단계의 의료 기술 회사로서, 2025년 5월 15일 오전 8시 30분 ET에 사업 업데이트 컨퍼런스 콜 및 웹캐스트를 진행할 예정임을 발표했습니다. 통화 중에 회장 겸 CEO인 Lishan Aklog 박사가 사업 현황과 운영 및 성장 전략에 대한 개요를 제공하고, 사장 겸 CFO인 Dennis McGrath가 2025년 1분기 재무 결과를 논의할 예정입니다.
웹캐스트는 PAVmed 투자자 관계 웹사이트를 통해 접속할 수 있습니다. 미국 내 전화 참가자는 1-800-836-8184로, 국제 전화 참가자는 1-646-357-8785로 전화하여 "PAVmed 사업 업데이트" 콜에 참여할 수 있습니다. 컨퍼런스 후 30일 동안 회사 웹사이트에서 다시 듣기 서비스가 제공됩니다.
PAVmed (Nasdaq : PAVM, PAVMZ), une entreprise diversifiée de technologie médicale en phase commerciale, a annoncé une conférence téléphonique et un webcast pour une mise à jour commerciale prévue le 15 mai 2025 à 8h30 ET. Lors de cet appel, le président et PDG Lishan Aklog, M.D., présentera une mise à jour de l’activité ainsi qu’un aperçu des opérations et de la stratégie de croissance, tandis que le président et directeur financier Dennis McGrath discutera des résultats financiers du premier trimestre 2025.
Le webcast sera accessible via le site web des relations investisseurs de PAVmed. Les appelants américains peuvent composer le 1-800-836-8184, et les appelants internationaux le 1-646-357-8785 pour rejoindre l’appel « Mise à jour commerciale PAVmed ». Un replay sera disponible pendant 30 jours sur le site de la société après la conférence.
PAVmed (Nasdaq: PAVM, PAVMZ), ein diversifiziertes Unternehmen im Bereich der medizinischen Technologien in der kommerziellen Phase, hat eine Telefonkonferenz und Webcast zur Geschäftsaktualisierung für den 15. Mai 2025 um 8:30 Uhr ET angekündigt. Während des Anrufs wird Vorsitzender und CEO Lishan Aklog, M.D., ein Geschäftsupdate sowie einen Überblick über die Betriebsabläufe und Wachstumsstrategie geben, während Präsident und CFO Dennis McGrath die Finanzergebnisse für das erste Quartal 2025 erläutert.
Der Webcast ist über die Investor-Relations-Website von PAVmed zugänglich. Anrufer aus den USA können die Nummer 1-800-836-8184 wählen, internationale Anrufer die Nummer 1-646-357-8785, um an dem „PAVmed Business Update“-Anruf teilzunehmen. Eine 30-tägige Wiedergabe ist nach der Konferenz auf der Website des Unternehmens verfügbar.
- None.
- None.
Conference Call and Webcast at 8:30 AM Eastern Time
The webcast will be available at the investor relations section of the Company's website at pavmed.com. Alternatively, to access the conference call by telephone,
Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at pavmed.com.
About PAVmed
PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer to mitigate the risks of esophageal cancer deaths. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. Veris is concurrently developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris Cancer Care Platform.
For more and for more information about PAVmed, please visit pavmed.com.
For more information about Lucid Diagnostics, please visit luciddx.com.
For more information about Veris Health, please visit verishealth.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/pavmed-to-hold-a-business-update-conference-call-and-webcast-on-may-15-2025-302442432.html
SOURCE PAVmed Inc.
FAQ
When is PAVmed (PAVM) hosting its Q1 2025 business update call?
How can investors access PAVmed's (PAVM) May 2025 business update call?
Who will be presenting at PAVmed's (PAVM) Q1 2025 business update call?
How long will the replay of PAVmed's May 2025 business update call be available?
